retatrutide phase 2 results 🚨Breaking: Retatrutide's first 3 T2D data just dropped. ▸ A1C: −2.0% at 40 weeks ▸ Weight: −36.6 lbs (−16.8%) at 12 mg ▸ No weight loss plateau — curve still descending Retatrutide Phase 2: Type 2

An underrated element of these diseases is that glucose uptake and energy utilization is much reduced in neurons

It starts fighting for the old weight again

Updated for 2026 with CMS-0057-F rule, Medicare GLP-1 Bridge program, MFN pricing deals, oral Wegovy approval, and AHIP reform pledges.

While agreements to lower the prices of GLP-1s wont immediately affect employer-sponsored health plans, they could eventually bring down costs.

What you'll get: an initial provider review and/or telehealth visit (depending on your state of residence), prescription medication (if approved), and prescriber access for questions, concerns, and mandatory 3-month provider check-ins